Bilge Butuner-Debelec

Ege, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Differential regulation of EMT-related pathways by inflammatory microenvironment in 3D prostate spheroids and tumor-stroma interaction models.

Differential regulation of EMT-related pathways by inflammatory microenvironment in 3D prostate spheroids and tumor-stroma interaction models.

Journal: Experimental cell research

Published: December 22, 2025

Semi-synthetic sapogenin derivatives inhibit inflammation-induced tumorigenic signaling alterations in prostate carcinogenesis.

Semi-synthetic sapogenin derivatives inhibit inflammation-induced tumorigenic signaling alterations in prostate carcinogenesis.

Journal: Steroids

Published: September 02, 2025

Plasmid DNA Delivery to Cancer Cells with Poly(L-lysine)-Based Copolymers Bearing Thermally Sensitive Segments: Balancing Polyplex Tightness, Transfection Efficiency, and Biocompatibility.

Plasmid DNA Delivery to Cancer Cells with Poly(L-lysine)-Based Copolymers Bearing Thermally Sensitive Segments: Balancing Polyplex Tightness, Transfection Efficiency, and Biocompatibility.

Journal: Pharmaceutics

Published: July 07, 2025

Borax pentahydrate as a promising boron-based angiogenesis inhibitor.

Borax pentahydrate as a promising boron-based angiogenesis inhibitor.

Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

Published: January 27, 2025

Discovery of selective TYK2 inhibitors: Design, synthesis, in vitro and in silico studies of promising hits with triazolopyrimidinone scaffold.

Discovery of selective TYK2 inhibitors: Design, synthesis, in vitro and in silico studies of promising hits with triazolopyrimidinone scaffold.

Journal: Bioorganic chemistry

Published: February 08, 2024

Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer.

Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer.

Journal: Turkish journal of biology = Turk biyoloji dergisi

Published: April 14, 2023

Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.

Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.

Journal: European journal of medicinal chemistry

Published: October 20, 2022

Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.

Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.

Journal: Frontiers in immunology

Published: August 26, 2022

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.

Journal: Journal of nanobiotechnology

Published: September 29, 2020

Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.

Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.

Journal: Archiv der Pharmazie

Published: November 01, 2019

Nutlin3a-Loaded Nanoparticles Show Enhanced Apoptotic Activity on Prostate Cancer Cells.

Nutlin3a-Loaded Nanoparticles Show Enhanced Apoptotic Activity on Prostate Cancer Cells.

Journal: Molecular biotechnology

Published: April 28, 2019

Oxidative DNA Damage-Mediated Genomic Heterogeneity Is Regulated by NKX3.1 in Prostate Cancer.

Oxidative DNA Damage-Mediated Genomic Heterogeneity Is Regulated by NKX3.1 in Prostate Cancer.

Journal: Cancer investigation

Published: March 07, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026